Predictive Teratology: Teratogenic Risk-Hazard Identification Partnered in the Discovery Process

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|9|9|971-977

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.9, 2008-11, pp. : 971-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology

By Czeizel Andrew E  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 283-303

Informa Healthcare

Access to resources Recommend Favorite

No significant teratogenic risk with sulfasalazine

By  

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective

By Bwire Robert   Freeman John   Houn Florence  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 3-8

Informa Healthcare

Access to resources Recommend Favorite

Chemical Categories for Health Hazard Identification: A Feasibility Study

By Rosenkranz H.S.   Cunningham A.R.  

Regulatory Toxicology and Pharmacology, Vol. 33, Iss. 3, 2001-06 ,pp. : 313-318

Academic Press

Access to resources Recommend Favorite

Risk Reduction in Drug Discovery and Development

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1087-1090

Bentham Science Publishers

Access to resources Recommend Favorite